✦ LIBER ✦

Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC)

✍ Scribed by López Rubio, Montserrat; Da Silva, Carolina; Loscertales, Javier; Seri, Cristina; Baltasar, Patricia; Colado, Enrique; Pérez Fernández, Inmaculada; Osma, Mar; Gomis, Federico; González, Marcos; Jarque, Isidro; Vargas, Manuel; Monzó, Encarnación; Monteagudo, Dolores; Orts, Maria Isabel; Pardal, Emilia; Carbonell, Félix; Perez Calvo, Cesar; Garcia-Marco, Jose A.

Book ID: 121400832
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 352 KB
Volume: 55
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2013.827187

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Routine clinical use of alemtuzumab in p

Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia : A nation-wide retrospective study in Austria

✍ Michael Fiegl; Andreas Falkner; Georg Hopfinger; Stefan Brugger; August Zabernig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 1 views

## Abstract ## BACKGROUND. In previous studies, alemtuzumab demonstrated considerable activity in patients with previously treated B‐cell chronic lymphocytic leukemia (CLL), including fludarabine‐refractory disease. In this retrospective study, the authors evaluated the benefit of alemtuzumab mono

5.40 Rituximab Maintenance in Patients w

5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)

✍ Francesc Bosch; Pau Abrisqueta; Neus Villamor; María José Terol; Eva González-Ba 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 250 KB

5.44 Consolidation Therapy with Subcutan

5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)

✍ Alain Delmer; Olivier Tournilhac; Stéphane Leprêtre; Bruno Cazin; Pierre Feugier 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 113 KB